(Q50861959)

24 March 2018

title

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community (English)

1 reference

24 March 2018

0 references

1 reference

1 reference

M Sudlow

1 reference

24 March 2018

R Thomson

1 reference

24 March 2018

B Thwaites

1 reference

24 March 2018

H Rodgers

1 reference

24 March 2018

R A Kenny

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

24 March 2018

published in

The Lancet

1 reference

24 March 2018

volume

352

1 reference

24 March 2018

issue

9135

1 reference

24 March 2018

page(s)

1167-1171

1 reference

24 March 2018

Stroke Prevention in Atrial Fibrillation Study. Final results

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Atrial fibrillation and mortality in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Screening for atrial fibrillation in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

An evidence based approach to individualising treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Warfarin for atrial fibrillation. The patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Recommendations on blood pressure measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Validation of a Population Screening Questionnaire to Assess Prevalence of Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Service provision and use of anticoagulants in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

7 January 2021

10.1016/S0140-6736(98)01401-9

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018